GeneDx Holdings Corp delivers personalized and actionable health insights to inform diagnosis, direct treatment and improve drug discovery... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
WGS is expected to report earnings to fall 27.66% to 36 cents per share on November 17
Q3'25
Est.
$0.36
Q2'25
Beat
by $0.38
Q1'25
Missed
by $0.29
Q4'24
Beat
by $0.56
Q2'23
Missed
by $0.33
The last earnings report on July 29 showed earnings per share of 50 cents, beating the estimate of 11 cents. With 829.83K shares outstanding, the current market capitalization sits at 3.63B.
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. WGS showed earnings on July 29, 2025. You can read more about the earnings report here.